Alpha-2 blocker

In this article, we will explore the fascinating world of Alpha-2 blocker, addressing its importance, impact and relevance in multiple areas. From its origins to its current evolution, Alpha-2 blocker has been the subject of numerous studies and debates that have contributed to expanding our understanding of this topic. Throughout these pages, we will immerse ourselves in its history, analyze its implications in contemporary society and reflect on its future. Likewise, we will examine how Alpha-2 blocker has transformed and continues to transform various areas, from science and technology to art and culture, offering a comprehensive and multidisciplinary vision to understand its complexity and scope. Join us on this exciting tour of Alpha-2 blocker!

Alpha-2 blockers (or α2 blockers) are a subset of the alpha blocker class of drugs and are antagonists to the α2 adrenergic receptor. They are mainly used in research, having found limited clinical application in human medicine. They are extensively used in veterinary medicine to reverse the effects of alpha-2 agonist drugs used as sedatives, like xylazine, medetomidine and dexmedetomidine. Alpha-2 blockers increase noradrenaline release.

Uses

Yohimbine, historically used as an aphrodisiac, is sometimes used in veterinary medicine (although now largely replaced by atipamezole) for reversing the effects of α2s such as medetomidine that are used as sedatives during surgery.[1]

The tetracyclic antidepressants mianserin and mirtazapine are α2 blockers, although their efficacy as antidepressants may come from their activity at other receptor sites.[citation needed]

Mechanistically, α2 blockers increase adrenergic, dopaminergic and serotonergic neurotransmitters and induce insulin secretion, decreasing blood sugar levels.[citation needed]

Withdrawal from α2 blockers can be difficult or dangerous as the global downregulation of neurotransmitters may cause symptoms of depression and other neurological problems, and increased blood sugar levels together with decreased insulin sensitivity can cause diabetes.[citation needed] Moreover, reduced microcirculation together with adrenaline supersensitivity in organs such as liver can occur.[citation needed]

Examples

Examples include atipamezole,[2] efaroxan, idazoxan,[3] yohimbine, and rauwolscine, phentolamine.

References

  1. ^ Lemke, KA (June 2004). "Perioperative use of selective alpha-2 agonists and antagonists in small animals". The Canadian Veterinary Journal. 45 (6): 475–80. PMC 548630. PMID 15283516.
  2. ^ Haapalinna A, Leino T, Heinonen E (November 2003). "The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats". Naunyn-Schmiedeberg's Arch. Pharmacol. 368 (5): 342–51. doi:10.1007/s00210-003-0827-z. PMID 14566451. S2CID 23897064.
  3. ^ Chopin P, Colpaert FC, Marien M (February 1999). "Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway". J. Pharmacol. Exp. Ther. 288 (2): 798–804. PMID 9918591.


Stub icon

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia